Un listing de conférences scientifiques et techniques

Accueil | Logiciel de gestion de conférence | Calendrier des conférences | Annonces publicitaires | Nous contacter | Qui nous sommes
Deutsch Français English
Vous êtes ici: AccueilCalendrier des conférencesSoins de santé → Pharmacologie et développement des médicaments - États-Unis
Cancer Vaccines
Advances in Cell Based Assays
Cuescience – Live-Streaming war noch nie so einfach.

Logiciel de gestion de conférences

Notre système de gestion de conférences en ligne (COMS) vous permet de:

  • gérer l'organisation de la conférence en ligne
  • gérer les inscriptions
  • gérer les paiements
  • gérer les soumissions de présentations
  • gérer la procédure de revue
  • sélectionner les présentations
  • produire le livre des résumés

Pour en savoir plus ...

Conférences - Pharmacologie et développement des médicaments - États-Unis met à la disposition de ses visiteurs des listes de conférences et réunions dans le domaine scientifique. Ces listes sont publiées pour le bénéfice des personnes qui cherchent une conférence, mais aussi, bien sûr, pour celui des organisateurs. Noter que, malgré tout le soin que nous apportons à la vérification des données entrées dans nos listes, nous ne pouvons accepter de responsabilité en ce qui concerne leur exactitude ou étendue. Pensez donc à vérifier les informations présentées avec les organisateurs de la conférence ou de la réunion avant de vous engager à y participer!

Les organisateurs peuvent soumettre une réunion ou une conférence pour inclusion dans nos listes, et ceci gratuitement.

1.FDA Inspections: What Regulators Expect and How to Prepare
 Dates 02 Sep 2015 → 03 Sep 2015
[ID=732682] Haut de la page
 LieuWashington DC, États-Unis
 Résumé This course is designed to provide participants with an understanding of the parameters, approaches, and concerns of FDA inspectors, and the tools for preparing, coping, and managing those inspections in pharmaceutical, biologics, and device facilities. All sessions involve case studies, examples and mock audit exercises.
 Sujets FDA Inspection, FDA Audit, FDA Compliance, FDA Inspection, FDA Inspection Process, FDA Inspection Procedure, FDA Inspection Guidance, Clinical Trial Inspection
 Page web
 Contact Peter Brown; Tél.: [+1 410-501-5777]; Email.:
 Sujets apparentés Essais cliniques; Législation en médecine et pharmacologie
2.The A to Z's of Microbial Control, Monitoring and Validation of Water Systems for Pharmaceuticals, Biologics, Medical Devices, Cosmetics, and Personal Care Products
 Dates 03 Sep 2015 → 04 Sep 2015
[ID=740619] Haut de la page
 LieuSpokane, États-Unis
 Résumé ll facilities manufacturing pharmaceuticals, biologics, medical devices, cosmetics, and personal care products are likely to have high purity water systems. In spite of this purity, microorganisms can flourish within these systems and lead to undesirable contamination of facility processes and their products.
 Sujets Pharmaceutical water systems seminar, water system compliance seminar, water system microbial control
 Page web
 Contact Referral; Tél.: [8887172436]; Email.:
 Sujets apparentés Chimie appliquée: Epuration des eaux
3.6th Non-Coding RNA and RNAi therapeutics
 Dates 09 Sep 2015 → 10 Sep 2015
[ID=720007] Haut de la page
 LieuPhiladelphia, États-Unis
 Résumé We invite you to attend the  6th Non-Coding RNA & RNAi Therapeutics Conference, which will take place  September 9-10, 2015  in  Philadelphia, PA. The conference will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues in the RNA research field. Emerging areas in RNA research provide great insight into promising therapeutic tools. Delivery has remained a solid focus for understanding how RNA has proven to play a vital and central role in all cellular function. The excitement and interest that CRISPR brings continues to progress the evolution of genome editing tools. We will also dive into application of aptamers in diagnostic and therapeutic settings. 
 Page web
4.2015 Pharma CI USA Conference & Exhibition
 Dates 10 Sep 2015 → 11 Sep 2015
[ID=710151] Haut de la page
 LieuParsippany, États-Unis
 Résumé The Pharma CI Conference & Exhibition (September 10-11, 2015, ) is THE INDUSTRY'S GOLD STANDARD for senior level pharmaceutical, biotechnology, medical device, and diagnostics professionals seeking the latest news and the rare chance to network with all the industry's luminaries. This is the biggest and best gathering of pharmaceutical competitive intelligence thought leaders (75+ speakers)! Join us at this premier gathering and network with other key decision makers as you learn about the most pressing and relevant issues facing the industry today. Enjoy the highest ratio of industry practitioners (pharma, biotech, medical device and diagnostics) of any pharma intelligence conference!
 Sujets -Pharma CI Conference & Exhibition -senior level pharmaceutical, biotechnology, medical device, and diagnostics professionals seeking the latest news and the rare chance to network with all the industry's luminaries
 Page web
 Contact Tél.: [212 228 7974]; Email.:
5.BPA2015 — BioPharm America™ 2015
 Dates 15 Sep 2015 → 17 Sep 2015
[ID=729849] Haut de la page
 LieuBoston, MA, États-Unis
 Résumé BioPharm America™ is where biotech industry partnerships get started. This three-day conference provides a proven and highly productive format for establishing new business relationships. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, the world’s leading web-based partnering system for the life science industry, BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®. In 2014, BioPharm America attracted 850+ delegates from over 500 companies who participated in 2350+ scheduled one-to-one meetings.
 Sujets partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance
 Page web
 Contact Elaine Bundy; Tél.: [+1 760 692 5919]; Email.:
 Sujets apparentés Biotechnologie
6.DOT — Discovery on Target
 Dates 21 Sep 2015 → 24 Sep 2015
[ID=729279] Haut de la page
 LieuBoston, États-Unis
 Résumé Cambridge Healthtech Institute will host its 13th Annual Discovery on Target event showcasing current and emerging “hot” targets for the pharmaceutical industry September 21-24, 2015 in Boston, MA. Spanning five days, the event attracts 1,000+ attendees (from 21 countries), composed of scientists/technologists, executives, directors, and managers from biopharma, academic, and healthcare organizations. In 2015 the event is comprised of 15 conference tracks, 3 Symposia, 15 short courses, 35+ interactive breakout discussion groups, an exhibit hall of 65 companies, and dedicated poster viewing and networking sessions. The 13th Annual Discovery on Target event assembles an impressive group of 200+ distinguished speakers who look forward to sharing their knowledge, best practices, and expertise with all attendees.
 Page web
 Contact Tél.: [7819745400]; Email.:
 Sujets apparentés Essais cliniques
7.EYE — Targeting Ocular Disorders
 Dates 22 Sep 2015 → 23 Sep 2015
[ID=729201] Haut de la page
 LieuBoston, États-Unis
 Résumé Ophthalmological pharmacology has historically lacked systematic understanding of disease mechanisms, especially of those for the back of the eye. This is now changing with the discovery of novel targets and pathways paired with a greater understanding of the role of genetics in ocular pathologies.The third annual Targeting Ocular Disorders will cover some of the most promising emerging therapies in the treatment of ocular diseases. Special focus with be given to age-related macular degeneration and retinopathy. Designated sessions will emphasize the role of precise imaging techniques and animal models in accelerating preclinical development. Recent solutions in drug delivery to the back of the eye will also be discussed.
 Page web
 Contact Tél.: [7819745400]; Email.:
 Sujets apparentés Ophtalmologie
8.Big DiP USA 2015 — Big Data in Pharma USA
 Dates 22 Sep 2015 → 24 Sep 2015
[ID=726373] Haut de la page
 LieuBoston, États-Unis
 Résumé Big DiP USA is back for the 3rd year running and the 2015 meeting will accelerate the development of your therapies and inform your commercial decision making through enhanced data interpretation.
 Sujets Big Data, Pharma,
 Page web
 Contact Charlotte Parnaby; Tél.: [+1 212 537 5898]; Email.:
9.BHR — Bio Pharma HR
 Dates 29 Sep 2015 → 30 Sep 2015
[ID=725222] Haut de la page
 LieuBoston, États-Unis
 Résumé BioPharma HR is the definitive meeting place for progressive Life Sciences HR leaders to challenge traditional thinking and engage in a disruptive conversation about the future of HR in our industry.
 Sujets Life Sciences, HR, Bio Pharma
 Page web
 Contact Charlotte Parnaby; Tél.: [(+44 (0)20 3141 8700)]; Email.:
 Dates 05 Oct 2015 → 06 Oct 2015
[ID=723820] Haut de la page
 LieuJersey City, États-Unis
 Résumé This annual Alzheimer's Drug Discovery Foundation (ADDF) conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias. The ADDF’s funded investigators and top level scientists in the field will present on their current research progress and stimulate discussion. The conference offers ample opportunities for collaboration and partnering.
 Sujets Alzheimer's, dementia, drug discovery
 Page web
 Contact Sara Classen; Tél.: [(212)901-8009]; Email.:
 Sujets apparentés Neurologie
11.SOS-2015 — Science of Stability Conference 2015
 Dates 12 Oct 2015 → 14 Oct 2015
[ID=728922] Haut de la page
 LieuGroton, États-Unis
 Résumé Establishing and improving the shelf-life of pharmaceuticals, nutraceuticals and other consumer goods is critical for taking product development to the next level. Despite this, fundamental aspects of Stability Science still remain mysterious to many. Join us to learn about the very latest findings from Industry and Academia. While most Stability Conferences focus on regulations and requirements; here at SOS-2015 "It's all about the Science."
 Sujets stability, drug stability, stability science, science of stability, its all about the science, pharmaceutical stability, Latest theories on the role of moisture and temperature on chemical reactions in solids, Use of in silico modeling for degradation mechanisms, Recent findings in oxidation chemistry related to peroxides, Amorphous dispersion, Use of accelerated stability for formulation development
 Page web
 Contact Elise Napper; Tél.: [+1.860.237.5800]; Email.:
12.AMS USA 2015 — World Anti-Microbial Congress USA 2015
 Dates 19 Oct 2015 → 20 Oct 2015
[ID=726400] Haut de la page
 LieuWashington, DC, États-Unis
 Résumé The World AntiMicrobial Resistance Congress USA gathers key stakeholders from government, funding agencies, pharma, academia and payers to discuss the urgent need for new antibiotics. President Obama has outlined his 5-year action plan to fight AMR and is seeking to double the AMR funding to $1.2B, but the bigger challenge is how to deliver these actions.This 2-day conference presents solutions through key notes, case study presentations, expert opinion and roundtable discussions, and invites key influencers such as BARDA, NIH, FDA, grant agencies, pharma and academia, in the AMR discussion. This is the 2-day exhibition and conference you cannot afford to miss.
 Sujets Private funding for antibiotic research, Generating an antimicrobial from natural products using a molecular approach, Genome mining to achieve novel antibiotic research, screening membrane-active compounds for antibiotic efficacy, and many more
 Page web &utm_campaign=COMS Listing
 Contact Freya Smale; Tél.: [646-619-1811]; Email.:
13.Antibody Drug Conjugates Conference
 Dates 22 Oct 2015 → 23 Oct 2015
[ID=717310] Haut de la page
 LieuBoston, États-Unis
 Résumé We invite you to attend the Antibody Drug Conjugates Conference, which will take place October 22-23, 2015 in Boston, MA. This event will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the emergence of recent data from ADC clinical trials, new linkers and payloads, personalized healthcare, site specific attachment, and ADC therapeutics. With the field of antibody drug conjugates rapidly expanding and the increasing number of ADC clinical trials, novel therapeutics are emerging. The ADC therapeutic area combines synthetic chemistry with rationale biology and is advancing monoclonal antibody treatments into the realm of precision medicine with improved effectiveness and therapeutic indices.
 Sujets I. Advances in Protein Modeling and Engineering Breakthroughs II. Novel Payloads and Linker Technology III. Pre-Clinical and Clinical Advances IV. Translational Considerations V. ADC Applications Beyond Oncology
 Page web
 Contact Kristen Starkey; Tél.: [626-256-6405]; Email.:
 Sujets apparentés Biotechnologie
14.3rd Antibody & Protein Therapeutics Conference
 Dates 22 Oct 2015 → 23 Oct 2015
[ID=717331] Haut de la page
 LieuBoston, États-Unis
 Résumé We welcome you to the 3rd Antibody & Protein Therapeutics Conference, which will be held October 22-23, 2015 in Boston, MA. This conference strives to connect industry and academic researchers in the protein therapeutics field to facilitate discussion on the current state of the industry and discuss recent studies and challenges involved in therapeutic development. Representatives from big pharma, academic institutions and government research labs will present data and case studies on key topics including antibody drug conjugates, bispecific antibodies, antibody combinations, and check point inhibiting antibodies. Attend to learn and network with key opinion leaders in a highly interactive and intimate environment!
 Sujets I. Advances in Protein Modeling and Engineering Breakthroughs II. Therapeutic Applications of Antibodies & Proteins III. Novel Bispecific and Multispecific Antibodies & Proteins IV. Preclinical Development and Clinical Trials V. New Target Identification Methods
 Page web
 Contact Kristen Starkey; Tél.: [626-256-6405]; Email.:
 Sujets apparentés Biotechnologie
15.2015 American Association of Pharmaceutical Scientists Annual Meeting & Exposition
 Dates 25 Oct 2015 → 29 Oct 2015
[ID=699152] Haut de la page
 LieuOrlando, États-Unis
 Page web
16.2nd Annual Drug Discovery USA Congress
 Dates 29 Oct 2015 → 30 Oct 2015
[ID=718037] Haut de la page
 LieuBoston, États-Unis
 Résumé Oxford Global’s 2nd Annual Drug Discovery USA Congress brings together over 150 industry leaders to discuss recent developments in drug discovery and medicinal chemistry.
 Sujets drug discovery, GPCR, Ion channel, assay development, screening, flow cytometry, high content analysis, medicinal chemistry, PPI, Computational chemistry, discovery chemistry, synthtetic chemistry, drug design, cheminformatics, discovery data
 Page web
 Contact Guillaume Alonso; Tél.: [+44 (0)1865 248 455]; Email.:
 Sujets apparentés Chimie informatique
17.American Association for Laboratory Animal Science 66th National Meeting
 Dates 01 Nov 2015 → 05 Nov 2015
[ID=699247] Haut de la page
 LieuPhoenix, États-Unis
 Résumé Each fall since 1950, the American Association for Laboratory Animal Science has held its annual National Meeting. During the five days of the meeting, members and nonmembers come together to enjoy the workshops, lectures, poster sessions, and exhibits. The program is designed to have topics relevant to the entire membership. Exhibitors have an opportunity to interact with AALAS members from the academic community, research institutions, government organizations, and commercial companies. The AALAS National Meeting is the largest gathering in the world of professionals concerned with the production, care, and use of laboratory animals.
 Page web
 Sujets apparentés Essais cliniques; Législation en médecine et pharmacologie
18.Vaccines R&D-2015 — International Conference on Vaccines Research & Development
 Dates 02 Nov 2015 → 04 Nov 2015
[ID=679427] Haut de la page
 LieuBaltimore, États-Unis
 Résumé United Scientific Group welcomes International Conference on Vaccines Research & Development (Vaccines R&D-2015) in Baltimore, USA during November 02-04, 2015.

The Conference aims at bringing together professors, researchers, scientists, academicians and other professionals in vaccine community to exchange and discuss their original research results, practical development experiences, technological achievements and new ideas for developing future vaccines.

The meeting features highly informative and interactive sessions to encourage the exchange of ideas across a broad range of disciplines including the latest vaccine technologies, product development initiatives being used to develop new or improved vaccines.

 Sujets Basic vaccinology, Influenza vaccines/virus, Ebola outbreak, Vaccines discovery development & formulation, Novel vaccines, New vaccine adjuvants, Clinical trials, Emerging infectious diseases, Passive vaccines-therapeutic antibodies against infectious diseases, HIV/AIDS vaccines, Immunoinformatics, Cancer vaccines, HPV vaccines
 Page web
19.CSDD 2015 — International conference on Clinical Sciences and Drug Discovery
 Dates 02 Nov 2015 → 04 Nov 2015
[ID=731687] Haut de la page
 LieuBaltimore, Maryland, États-Unis
 Résumé Clinical Sciences and Drug Discovery-2015 (CSDD-2015) has been designed to have an insight on the drug discovery and targeted drug delivery systems. It is important that the professionals should meet up on regular basis to interact, network and exchange ideas and concepts. It is only by sharing ideas we develop new one that catalyze technological advancement. This conference is all set to bring together the global industry leaders, policy makers, innovators, public health researchers, pharmaceutical scientists, internists and primary care physicians together on one platform discussing the new opportunities in the transition
 Sujets Drug designing, Drug discovery, CNS drug discovery, Cancer targeted drug delivery, Cardiovascular drug discovery, Biomarkers, Biologics, Biopharmaceuticsls, small molecules, Adjuvants, Anti-infectives, Pharmacokinetics, Analytical sciences, Medicinal Chemistry, Medical Imaging, Computer Aided Drug Designing, Clinical trials, Drug efficacy, Toxicology
 Page web
 Contact Organizing Secretary CSDD 2015; Tél.: [408-426-4833]; Email.:
 Sujets apparentés Essais cliniques; Biochimie et chimie médicale, toxicologie
20.Vaccines Against Antigenically Variable Viruses
 Dates 05 Nov 2015 → 08 Nov 2015
[ID=702427] Haut de la page
 LieuAmes, États-Unis
 Page web
21.2015 NEI Psychopharmacology Congress
 Dates 12 Nov 2015 → 15 Nov 2015
[ID=699190] Haut de la page
 LieuOrlando, États-Unis
 Page web
22.3rd Steroid Research Congress
 Dates 15 Nov 2015 → 18 Nov 2015
[ID=683454] Haut de la page
 LieuChicago, États-Unis
 Résumé As with previous successful meetings in the series this conference will bring together international delegates to address state-of-the-art approaches in the molecular basis of steroid-related common human diseases. The program will reflect the interdisciplinary nature of steroid research, involving aspects of analytics, chemistry, biology, medicine, bioinformatics and drug discovery.
 Page web
 Sujets apparentés Biologie; Endocrinologie
23.Biosimilars and Biobetters USA
 Dates 16 Nov 2015 → 17 Nov 2015
[ID=735086] Haut de la page
 LieuIselin, États-Unis
 Résumé Through a series of panel discussions, presentations and workshops, Biosimilars & Biobetters USA 2015 will offer effective strategies and solutions for developing cost effective biosimilars for the future. With an in-depth focus on the current and future landscape of the biosimilars market, this year's conference will allow input from key industry experts in the field to engage in meaningful and important discussions on how to accelerate drug development to market.
 Page web
24.Therapeutic Area Partnerships 2015
 Dates 18 Nov 2015 → 20 Nov 2015
[ID=735171] Haut de la page
 LieuBoston, États-Unis
 Résumé Therapeutic Area Partnerships is a uniquely efficient gathering bringing together decision-makers to assess the most promising drug programs available for partnering in Cardiovascular/Metabolic Diseases, Neuroscience, Anti-Inflammatory/Autoimmune Diseases, Oncology/Immuno Oncology, Infectious and Emerging Diseases, Advanced Therapies (Cell, Gene and Stem Therapies), Orphan and Rare Diseases, and Academic Technology Transfer.
 Page web
25.Genetic Rx Boston
 Date de début03 Dec 2015
[ID=699200] Haut de la page
 LieuBoston, États-Unis
 Résumé Genetic Rx will take place at Harvard Medical School and will bring together academics and key industry leaders to discuss the emergence of new genetic medicines as well as the treatment of patients with rare and ultra-rare genetic diseases.
 Page web
 Sujets apparentés Médecine (en général)
26.The Biomarker Conference
 Dates 10 Dec 2015 → 11 Dec 2015
[ID=732217] Haut de la page
 LieuOrlando, États-Unis
 Résumé At 'The Biomarker Conference' to be held on 10 - 11 December 2015 in Orlando, Florida, USA 150+ biomarker experts will be gathering to discuss emerging pathways and breakthroughs in biomarker discovery and successful validation in consort with the regulatory guidelines and evolving cost-effective technologies that can help increase success rates in novel biomarker discovery and approvals for clinical utility.
 Sujets florida, biomarker discovery, biomarker validation, biomarkers in clinical trials, companion diagnostics, biobank research, clinical oncology, preclinical safety, pharmacogenomics, pharmacogenetics, drug discovery, genomics, bio-informatics, personalized medicine, translational research, biomarkers toxicity, molecular informatics, biomarker imaging, epigenetics biomarkers, systems biology, december, usa, orlando, conferences, summit, expo, congress, Pfizer, Roche, Janssen Research & Development, Novartis Institutes For BioMedical Research, Astrazeneca, Merck Serono, Harvard Medical School, The Wistar Institute, National Cancer Institute, National Institutes Of Health, Moffitt Cancer Center
 Page web
 Contact Ajay Nimbalkar; Tél.: [+912067046816]; Email.:
 Sujets apparentés Génomique et bio-informatique
27.NGS Data Analysis and Informatics Conference
 Dates 10 Dec 2015 → 11 Dec 2015
[ID=732213] Haut de la page
 LieuOrlando, États-Unis
 Résumé Growing collaborations between organisations and increased NGS data sharing between locations has created a need for a more robust and secure data storage, analysis, access and integration system while ensuring high quality of the NGS data being produced. At the ‘NGS Data Analysis and Informatics Conference' to be held on 10 - 11 December 2015 in Orlando, Florida - USA we will be discussing strategies to accurately analyse and scale-up informatics for the data generated through the NGS technology while ensuring quality & scalability of the data.
 Sujets NGS, next generation sequencing, precision medicine, biomarkers, genome studies, drug discovery, clinical diagnosis, data analysis, computational biology
 Page web
 Contact Ajay Nimbalkar; Tél.: [((+912067046816))]; Email.:
 Sujets apparentés Génomique et bio-informatique; Biologie des systèmes
28.Novel Immunotherapeutics Summit
 Dates 25 Jan 2016 → 26 Jan 2016
[ID=738687] Haut de la page
 LieuSan Diego, États-Unis
 Résumé We invite you to GTCbio's Novel Immunotherapeutics Summit, which takes place on January 25 - 26, 2016 in San Diego, CA. The summit will bring together our usual balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the various topics below.
 Sujets Cytokines & Inflammation, Immunotherapeutics & Immunomonitoring, Immunogenicity & Immunotoxicity, Allergy, Asthma, & COPD
 Page web
 Contact Kristen Starkey; Tél.: [626-256-6405]; Email.:
 Sujets apparentés Maladies Infectieuses
29.LDN 2016 — The LDN 2016 AIIC Conference
 Dates 19 Fév 2016 → 21 Fév 2016
[ID=725292] Haut de la page
 LieuOrlando, États-Unis
 Résumé The LDN AIIC 2016 Conference is produced by the LDN Research Trust, a non-profit, Registered Charity dedicated to raising awareness as well as funding research and clinical trials of LDN as a treatment for Crohn's Disease, Colitis, Autism, IBS, Lupus, Fibromyalgia, Rheumatoid, Arthritis, Chronic Pain and other auto-immune diseases. The central role of the conference is to review, compare and contrast the most recent LDN-related data and treatments. It also offers compelling examples, experiences and case studies from many of the world’s leading experts, practitioners and patients who are using LDN to achieve positive, and in many cases, life-changing results.
 Sujets LDN, MS, Chrohns, Fibromyalgia, Chronic Pain, Autism, Colitis, ME/CFS
 Page web
 Contact Jim Warner; Tél.: [+1 770-663-8803]; Email.:
 Sujets apparentés Neurologie; Médecine (en général)
30.G Protein-Coupled Receptors: Structure, Signaling and Drug Discovery
 Dates 21 Fév 2016 → 25 Fév 2016
[ID=739931] Haut de la page
 LieuKeystone, États-Unis
 Résumé The field of G protein-coupled receptors has recently seen major advances in high-resolution structure determination, as well as the validation of novel paradigms of drug action, such as allosteric modulation and biased agonism, as likely universal mechanisms. These studies are opening new insights into the diversity of this receptor superfamily, teaching us new lessons in receptor functionality and hinting at novel avenues to investigate. At the same time, we are seeing exciting discoveries in GPCR intracellular signaling and physiology. The timing is right to bring together researchers in these different areas. This Keystone Symposia meeting will focus on the interplay between these discoveries and how they are being used to advance GPCR-based research toward improved clinical outcomes. 
 Page web
 Sujets apparentés Biologie moléculaire
31.Pharmacokinetics for Pharmaceutical Scientists Course
 Dates 29 Fév 2016 → 04 Mar 2016
[ID=725710] Haut de la page
 LieuSan Francisco, États-Unis
 Page web
32.HIV Vaccines
 Dates 20 Mar 2016 → 24 Mar 2016
[ID=740131] Haut de la page
 LieuOlympic Valley, États-Unis
 Résumé HIV Persistence: Pathogenesis and Eradication. The development of a safe and effective HIV vaccine remains a major global health priority and a complex problem to solve. Current efforts emphasize an ability to elicit systemic and mucosal antibody responses capable of preventing the acquisition of infection. Evidence from multiple passive transfer experiments in non-human primates, as well as from studies of immunologic correlates of modest efficacy in the RV144 Thai trial, support the notion that both neutralizing and non-neutralizing antibodies have potential to prevent infection. Major advances have been made in understanding the epitopes, structures and evolutionary pathways of broadly neutralizing antibodies, leading to new avenues to pursue for vaccine design. The extraordinary breadth and potency of some recently discovered neutralizing antibodies has generated additional interest in potential therapeutic applications, including cure strategies. There has also been a steady increase in knowledge of other types of antiviral antibodies and their effector functions that may be important for vaccines. This meeting aims to cover a range of topics including: 1) Initial virus transmission events for vaccine intervention, 2) Non-neutralizing antibody correlates of sterilizing immunity; 3) Epitopes, structures and ontogeny of broadly neutralizing antibodies; 4) Novel vaccine concepts for broadly neutralizing antibody induction; and 5) Immunotherapy. Emphasis will be placed on recent unpublished findings in key areas that hold the greatest promise for rapid progress toward an effective vaccine.
 Page web
 Sujets apparentés Maladies Infectieuses
33.World Orphan Drug Congress USA 2016
 Dates 20 Avr 2016 → 22 Avr 2016
[ID=728892] Haut de la page
 LieuWashington, DC, États-Unis
 Résumé This is the largest global industry gathering for the orphan drug industry and rare disease community where pharma, biotech, patient groups, academia, regulators, payers and investors gather to talk about strategies to expedite orphan drug development. We grew the event to 600 participants in 2015 with over 25 countries represented. cademic medical centers, HCPs, clinicians and point of care diagnostics will be a new focus in 2016. Specific orphan products and their Marketing Managers will also be a stronger focus along with gene therapy as the future rare disease cure. Meet CEOs, VPs and Directors of the following business units from pharma and biotech: R&D, Business Development, Regulatory Access, Market Access, Commercial, Marketing and Brand/Product Managers.You will also meet Scientists, Investigators and Engineers as well as relevant Heads from university departments studying rare disease and developing a cure.
 Sujets In terms of content, people are talking more and more about gene therapy orphan drugs. 2016 will feature the latest content on gene therapy orphan drugs in development. The other new addition to 2016 is a workshop for clinicians. This workshop is designed to enable marketers to help clinicians get educated on rare diseases and orphan drugs so they can detect and diagnose rare diseases better and faster.
 Page web Service&utm_medium=Listing&utm_campaign=COMSListing
 Contact Freya Smale; Tél.: [646-619-1811]; Email.:

États-Unis: liste de tous les évènements/conférences.

Dernière mise à jour: 18 août 2015